Harvard Bioscience, Inc. (HBIO)
5.87
-0.13
(-2.17%)
USD |
NASDAQ |
Jun 18, 16:00
5.90
+0.03
(+0.51%)
After-Hours: 20:00
Harvard Bioscience SG&A Expense (Quarterly) : 10.04M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 10.04M |
| December 31, 2025 | 9.212M |
| September 30, 2025 | 8.789M |
| June 30, 2025 | 8.801M |
| March 31, 2025 | 10.16M |
| December 31, 2024 | 10.20M |
| September 30, 2024 | 10.56M |
| June 30, 2024 | 11.08M |
| March 31, 2024 | 11.87M |
| December 31, 2023 | 11.51M |
| September 30, 2023 | 11.54M |
| June 30, 2023 | 11.53M |
| March 31, 2023 | 12.31M |
| December 31, 2022 | 11.81M |
| September 30, 2022 | 12.14M |
| June 30, 2022 | 12.57M |
| March 31, 2022 | 13.01M |
| December 31, 2021 | 13.46M |
| September 30, 2021 | 11.64M |
| June 30, 2021 | 12.13M |
| March 31, 2021 | 11.72M |
| December 31, 2020 | 11.15M |
| September 30, 2020 | 9.987M |
| June 30, 2020 | 9.949M |
| March 31, 2020 | 12.34M |
| Date | Value |
|---|---|
| December 31, 2019 | 11.44M |
| September 30, 2019 | 11.90M |
| June 30, 2019 | 10.58M |
| March 31, 2019 | 11.96M |
| December 31, 2018 | 12.55M |
| September 30, 2018 | 10.68M |
| June 30, 2018 | 11.57M |
| March 31, 2018 | 11.03M |
| December 31, 2017 | 8.725M |
| September 30, 2017 | 7.952M |
| June 30, 2017 | 7.664M |
| March 31, 2017 | 8.266M |
| December 31, 2016 | 10.26M |
| September 30, 2016 | 9.806M |
| June 30, 2016 | 10.32M |
| March 31, 2016 | 11.05M |
| December 31, 2015 | 10.30M |
| September 30, 2015 | 10.03M |
| June 30, 2015 | 10.05M |
| March 31, 2015 | 10.03M |
| December 31, 2014 | 9.504M |
| September 30, 2014 | 8.243M |
| June 30, 2014 | 8.554M |
| March 31, 2014 | 8.683M |
| December 31, 2013 | 5.431M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 465.00M |
| Bio-Rad Laboratories, Inc. | 212.40M |
| Bruker Corp. | 242.10M |
| Danaher Corp. | 1.86B |
| Illumina, Inc. | 272.00M |